This article investigates the features, outcomes, and treatment efficacy of postanoxic status epilepticus (SE) following cardiac arrest. The researchers conducted a multicenter pooled analysis of patient data, including the TELSTAR trial and two registries, to identify predictors of neurological recovery and determine when antiseizure medication is beneficial. The study highlights that definite or possible SE does not always lead to a poor outcome, with a significant percentage of patients achieving good recovery, especially when certain unfavorable prognostic factors are absent. Key findings suggest that SE cessation and higher doses of specific antiseizure medications are associated with better outcomes, particularly in cases of definite SE, emphasizing the importance of early EEG monitoring and tailored treatment strategies. The authors acknowledge that further randomized controlled trials are necessary to establish definitive treatment guidelines.